Cargando…

COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review

BACKGROUND: The role of humoral immunity has been well established in reducing infection risk and facilitating viral clearance in patients with COVID-19. However, the relationship between specific antibody responses and severity of COVID-19 is less well understood. METHODS: To address this question...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Jessica M., Faruqi, Aiman J., Sullivan, James K., Calabrese, Cassandra, Calabrese, Leonard H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pathogens and Immunity 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150936/ https://www.ncbi.nlm.nih.gov/pubmed/34056149 http://dx.doi.org/10.20411/pai.v6i1.435

Ejemplares similares

Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity
por: Calabrese, Cassandra, et al.
Publicado: (2022)

Breakthrough SARS‐CoV‐2 infections in immune mediated disease patients undergoing B cell depleting therapy: A retrospective cohort analysis
por: Calabrese, Cassandra M, et al.
Publicado: (2022)

Long COVID: defining the role of rheumatology in care and research
por: Calabrese, Leonard H, et al.
Publicado: (2022)

Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications
por: Calabrese, Cassandra, et al.
Publicado: (2022)

The Evolving Role of the Rheumatology Practitioner in the Care of Immunocompromised Patients in the COVID‐19 Era
por: Calabrese, Leonard H., et al.
Publicado: (2022)

Rituximab: Humoral immunodeficiency: case report
Publicado: (2021)

Infections in the Era of Targeted Therapies: Mapping the Road Ahead
por: Calabrese, Leonard H., et al.
Publicado: (2020)

Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy
por: Antolí, Arnau, et al.
Publicado: (2022)

Evaluation of pulmonary findings in patients with humoral immunodeficiency
por: Karalı, Zuhal, et al.
Publicado: (2020)

Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
por: Calabrese, Cassandra, et al.
Publicado: (2019)

Case Report: Zellweger Syndrome and Humoral Immunodeficiency: The Relevance of Newborn Screening for Primary Immunodeficiency
por: Fazi, C., et al.
Publicado: (2022)

Primary ciliary dyskinesia and humoral immunodeficiency - what is the missing link?
por: Boon, Mieke, et al.
Publicado: (2013)

Progressive Immunodeficiency with Gradual Depletion of B and CD4(+) T Cells in Immunodeficiency, Centromeric Instability and Facial Anomalies Syndrome 2 (ICF2)
por: Sogkas, Georgios, et al.
Publicado: (2019)

Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network
por: Cirillo, Emilia, et al.
Publicado: (2022)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

Value of the Overall Pneumococcal Polysaccharide Response in the Diagnosis of Primary Humoral Immunodeficiencies
por: Lopez, Benjamin, et al.
Publicado: (2017)

Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy
por: Gernez, Yael, et al.
Publicado: (2018)

B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased
por: Ihlow, Jana, et al.
Publicado: (2021)

Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients
por: Schroeder, H. W., et al.
Publicado: (2012)

T-cell activation discriminates subclasses of symptomatic primary humoral immunodeficiency diseases in adults
por: Picat, Marie-Quitterie, et al.
Publicado: (2014)

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency
por: Honjo, Kazuhito, et al.
Publicado: (2020)

Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple Myeloma
por: Hammons, Lindsay R., et al.
Publicado: (2022)

Development of cellular and humoral response against WT1 protein vaccination in mice
por: Nicoli, Paolo, et al.
Publicado: (2015)

Historical overview
por: Calabrese, Leonard H
Publicado: (2013)

Treatment of SLE: bridging the gap from clinical trials to the clinic - a meeting report
por: Calabrese, Leonard H
Publicado: (2013)

Why Mindfulness/Meditation Is a “No-Brainer” for Health-Care Professionals
por: Calabrese, Leonard H
Publicado: (2018)

Long COVID in inflammatory rheumatic diseases—what's in a name?
por: Calabrese, Leonard H
Publicado: (2023)

CD20+ B Cell Depletion in Systemic Autoimmune Diseases: Common Mechanism of Inhibition or Disease-Specific Effect on Humoral Immunity?
por: Pateinakis, Panagiotis, et al.
Publicado: (2014)

Humoral and Cellular Immune Responses to SARS–CoV‐2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion
por: Simon, David, et al.
Publicado: (2021)

Long-term Clinical Outcome of Antibody Replacement Therapy in Humoral Immunodeficient Adults With Respiratory Tract Infections
por: van Kessel, Diana A., et al.
Publicado: (2017)

Editorial: Infection-Related Rheumatic Diseases
por: Thomas, Konstantinos, et al.
Publicado: (2021)

Humor in Workplace Leadership: A Systematic Search Scoping Review
por: Rosenberg, Caroline, et al.
Publicado: (2021)

A scoping research literature review to explore bereavement humor
por: Wilson, Donna M., et al.
Publicado: (2022)

Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis
por: Kitamura, Mineaki, et al.
Publicado: (2022)

Complement Depletion Improves Human Red Blood Cell Reconstitution in Immunodeficient Mice
por: Chen, Bing, et al.
Publicado: (2017)

Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
por: Delgado-Fernández, Marcial, et al.
Publicado: (2022)

Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature
por: Delgado-Fernández, Marcial, et al.
Publicado: (2022)

Association of Primary Humoral Immunodeficiencies With Psychiatric Disorders and Suicidal Behavior and the Role of Autoimmune Diseases
por: Isung, Josef, et al.
Publicado: (2020)

COVID-19 Infection in Patients with Humoral Immunodeficiency: A Case Series and Literature Review
por: Jalil, Maaz, et al.
Publicado: (2022)

Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
por: Asplund Högelin, Klara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_akrl9f8sosccgtgqjtatlvhro3